Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.960
https://www.valueinhealthjournal.com/article/S1098-3015(16)32326-9/fulltext
Title :
Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32326-9&doi=10.1016/j.jval.2016.09.960
First page :
A512
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
904